drugset / Trial / NCT04275986
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective single-arm study of endoscopic resection (ER) following concurrent chemoradiotherapy for stage I esophageal squamous cell carcinoma, to find if the treatment combination is useful by assessing its safety and efficacy.
Timeline
- Start
- 2020-01-20
- Primary completion
- 2024-01
- Completion
- 2024-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nedaplatin | Small molecule | 25 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 45 mg/m2 | — |